Non-transferrin-bound iron in plasma following administration of oral iron drugs
- 298 Downloads
Non-transferrin-bound iron (NTBI) was detected in serum samples from volunteers with normal iron stores or from patients with iron deficiency anaemia after oral application of pharmaceutical iron preparations. Following a 100 mg ferrous iron dosage, NTBI values up to 9 μM were found within the time period of 1–4 h after administration whereas transferrin saturation was clearly below 100%. Smaller iron dosages (10 and 30 mg) gave lower but still measurable NTBI values. The physiological relevance of this finding for patients under iron medication has to be elucidated.
KeywordsNon-transferrin-bound iron—NTBI Oral iron drugs Transferrin saturation Iron medication Risk factor
- Nielsen P, Gabbe EE, Fischer R, Heinrich HC (1994) Bioavailability of iron from oral ferric polymaltose in humans. Arzneim Forsch 44:743–748Google Scholar
- Schümann K, Kroll S, Weiss G, Frank J, Biesalski HK, Daniel H, Friel J, Solomons NW (2005) Monitoring of hematological, inflammatory and oxidative reactions to acute oral iron exposure in human volunteers: preliminary screening for selection of potentially-responsive biomarkers. Toxicology 212:10–23PubMedCrossRefGoogle Scholar
- van Campenhout A, van Campenhout C, Lagrow A, Manuel-y-Keenoy B (2007) Iron-induced oxidative stress in haemodialysis patients: a pilot study on the impact of diabetes. Biometals onlineGoogle Scholar